Overview
- 101 inspections across 93 sites are on record.
- 108 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2018-09-12.
At a glance
Inspections
101
Sites
93
Observations
108
Career since
Jan 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Kimball A. Johnson, M.D. | 12 Sep 2018 | Human Drugs | |
| David B. DeLurgio, M.D. | 13 Aug 2018 | Medical Devices & Rad Health | |
| Dr. Craig Coopersmith, MD | 19 Jun 2018 | Human Drugs | |
| MedaPhase, Inc | 14 May 2018 | Human Drugs | |
| Dr. Harvey DuBiner | 17 Apr 2018 | Medical Devices & Rad Health |
Sites inspected
Kimball A. Johnson, M.D.Decatur, United States1 insp.
David B. DeLurgio, M.D.Atlanta, United States1 insp.
Dr. Craig Coopersmith, MDAtlanta, United States1 insp.
MedaPhase, IncNewnan, United States1 insp.
Dr. Harvey DuBinerMorrow, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Ernest H Blackwood1 shared
Gabriel R Mclemore1 shared
Miaja Umaedi1 shared
Lareese K Thomas1 shared
Sheri S Oliver1 shared
April R Bowen1 shared
Full investigator report
Get the verbatim findings behind Myla D Chapman's 108 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site